
Krka Investor Relations Material
Latest events

Q1 2024
Krka

Q1 2025
16 May, 2025

H2 2024
10 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Krka d. d.
Access all reports
Krka, d. d., Novo mesto is a Slovenia-based international generic pharmaceutical company. The company focuses on the development, production, marketing, and sales of pharmaceutical products for human health, including prescription pharmaceuticals, self-medication products, and cosmetics. Additionally, Krka extends its product range to animal health products. With a presence in more than 70 countries, Krka has established production and distribution centers in key markets such as Russia, Poland, Croatia, and Germany, supporting its global distribution network. The company's commitment to quality and innovation has been instrumental in its expansion and ability to meet diverse health needs worldwide. The company is headquartered in Novo Mesto, Slovenia, and its shares are listed on the Warsaw Stock Exchange.
Key slides for Krka d. d.


Q4 2024
Krka d. d.


Q4 2024
Krka d. d.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
KRK
Country
🇸🇮 Slovenia